Sandro Matosevic

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 20

Top Venues

Nature communications

Molecular pharmaceutics

Cancers

Journal of molecular medicine (Berlin, Germany)

Purdue University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Purdue University

United States

Assistant Professor :: Industrial and Physical Pharmacy

Publications

Kyle B Lupo, Xue Yao, Shambhavi Borde, Jiao Wang, Sandra Torregrosa-Allen, Bennett D Elzey, Sagar Utturkar, Nadia A Lanman, MacKenzie McIntosh, Sandro Matosevic
synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy. Nature communications 15 (1) (2024)
Kyle B Lupo, Xue Yao, Shambhavi Borde, Jiao Wang, Sandra Torregrosa-Allen, Bennett D Elzey, Sagar Utturkar, Nadia A Lanman, MacKenzie McIntosh, Sandro Matosevic
synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy. Nature communications 15 (1) (2024)
Soumyajit Das, Emmett Niemeyer, Zach A Leung, Tyler Fritsch, Sandro Matosevic
Human Natural Killer Cells Cryopreserved without DMSO Sustain Robust Effector Responses. Molecular pharmaceutics 21 (2) (2024)
Soumyajit Das, Emmett Niemeyer, Zach A Leung, Tyler Fritsch, Sandro Matosevic
Human Natural Killer Cells Cryopreserved without DMSO Sustain Robust Effector Responses. Molecular pharmaceutics 21 (2) (2024)
Kyle B Lupo, Xue Yao, Shambhavi Borde, Jiao Wang, Sandra Torregrosa-Allen, Bennett D Elzey, Sagar Utturkar, Nadia A Lanman, MacKenzie McIntosh, Sandro Matosevic
synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy. Nature communications 15 (1) (2024)
Kyle B Lupo, Xue Yao, Shambhavi Borde, Jiao Wang, Sandra Torregrosa-Allen, Bennett D Elzey, Sagar Utturkar, Nadia A Lanman, MacKenzie McIntosh, Sandro Matosevic
synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy. Nature communications 15 (1) (2024)
Soumyajit Das, Emmett Niemeyer, Zach A Leung, Tyler Fritsch, Sandro Matosevic
Human Natural Killer Cells Cryopreserved without DMSO Sustain Robust Effector Responses. Molecular pharmaceutics (2024)
Andrea M Chambers, Kyle B Lupo, Jiao Wang, Jingming Cao, Sagar Utturkar, Nadia Lanman, Victor Bernal-Crespo, Shadia Jalal, Sharon R Pine, Sandra Torregrosa-Allen, Bennett D Elzey, Sandro Matosevic
Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumors. eLife 11 (2022)
Andrea M Chambers, Jiao Wang, Tram N Dao, Kyle B Lupo, Paige Veenhuis, Mitchell G Ayers, Veronika Slivova, Aaron A Cohen-Gadol, Sandro Matosevic
Functional expression of CD73 on human natural killer cells. Cancer immunology, immunotherapy : CII 71 (12) (2022)
Xue Yao, Sandro Matosevic
Cryopreservation of NK and T Cells Without DMSO for Adoptive Cell-Based Immunotherapy. BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 35 (5) (2021)
Jiao Wang, Sandra Toregrosa-Allen, Bennett D Elzey, Sagar Utturkar, Nadia Atallah Lanman, Victor Bernal-Crespo, Matthew M Behymer, Gregory T Knipp, Yeonhee Yun, Michael C Veronesi, Anthony L Sinn, Karen E Pollok, Randy R Brutkiewicz, Kathryn S Nevel, Sandro Matosevic
Multispecific targeting of glioblastoma with tumor microenvironment-responsive multifunctional engineered NK cells. Proceedings of the National Academy of Sciences of the United States of America 118 (45) (2021)
Xue Yao, Joshua J Jovevski, Michaela F Todd, Rui Xu, Yining Li, Jiao Wang, Sandro Matosevic
Nanoparticle-Mediated Intracellular Protection of Natural Killer Cells Avoids Cryoinjury and Retains Potent Antitumor Functions. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 7 (9) (2020)
Sandro Matosevic
Reprogramming of natural killer cells and their use in immunotherapies of solid tumors. Immunotherapy 12 (9) (2020)
Kyle B Lupo, Sandro Matosevic
CD155 immunoregulation as a target for natural killer cell immunotherapy in glioblastoma. Journal of hematology & oncology 13 (1) (2020)
Tram N Dao, Sagar M Utturkar, Nadia Atallah Lanman, Sandro Matosevic
TIM-3 Expression Is Downregulated on Human NK Cells in Response to Cancer Targets in Synergy with Activation. Cancers 12 (9) (2020)
Jiao Wang, Sandro Matosevic
NT5E/CD73 as Correlative Factor of Patient Survival and Natural Killer Cell Infiltration in Glioblastoma. Journal of clinical medicine 8 (10) (2019)
Kyle B Lupo, Sandro Matosevic
Natural Killer Cells as Allogeneic Effectors in Adoptive Cancer Immunotherapy. Cancers 11 (6) (2019)
Jiao Wang, Kyle B Lupo, Andrea M Chambers, Sandro Matosevic
Purinergic targeting enhances immunotherapy of CD73+ solid tumors with piggyBac-engineered chimeric antigen receptor natural killer cells. Journal for immunotherapy of cancer 6 (1) (2018)
Jiao Wang, Sandro Matosevic
Adenosinergic signaling as a target for natural killer cell immunotherapy. Journal of molecular medicine (Berlin, Germany) 96 (9) (2018)
Sandro Matosevic
Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies. Journal of immunology research 2018 (2018)

Sandro Matosevic.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sandro Matosevic